Omega Healthcare Investors (NYSE: OHI) insider transactions
In the twelve months to 10 November 2026, executives and directors of Omega Healthcare Investors reported no open-market sales and no open-market purchases, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 1 October 2026 | Golem Lucas M. | Chief Accounting Officer | Grant or award | +64 | $39.37 | 1,770 | Form 4 |
| 1 October 2026 | Golem Lucas M. | Chief Accounting Officer | Returned to the company | −3 | $46.31 | 1,767 | Form 4 |
| 7 August 2026 | Egbuonu-Davis Lisa | Director | Gift | −5,131 | — | 17,301 | Form 4 |
| 1 July 2026 | Ballew Neal | Chief Accounting Officer | Grant or award | +168 | $37.25 | 4,676 | Form 4 |
| 1 July 2026 | Ballew Neal | Chief Accounting Officer | Returned to the company | −11 | $47.68 | 4,665 | Form 4 |
| 5 June 2026 | Whitman Burke W | Director | Grant or award | +3,778 | $43.67 | 47,931 | Form 4 |
| 5 June 2026 | Jacobs Kevin J | Director | Grant or award | +6,125 | $43.67 | 46,935 | Form 4 |
| 5 June 2026 | Egbuonu-Davis Lisa | Director | Grant or award | +3,778 | $43.67 | 22,432 | Form 4 |
| 1 April 2026 | Ballew Neal | Chief Accounting Officer | Grant or award | +168 | $37.25 | 4,516 | Form 4 |
| 1 April 2026 | Ballew Neal | Chief Accounting Officer | Returned to the company | −8 | $43.82 | 4,508 | Form 4 |
| 1 January 2026 | Ballew Neal | Chief Accounting Officer | Grant or award | +173 | $35.89 | 4,360 | Form 4 |
| 1 January 2026 | Ballew Neal | Chief Accounting Officer | Shares withheld for tax | −12 | $44.34 | 4,348 | Form 4 |
| 31 December 2025 | Stephenson Robert O | Chief Financial Officer | Gift | −31,426 | — | 147,000 | Form 4 |
| 31 December 2025 | Stephenson Robert O | Chief Financial Officer | Gift | +31,426 | — | 31,426 | Form 4 |
| 30 December 2025 | Stephenson Robert O | Chief Financial Officer | Gift | −3,850 | — | 178,426 | Form 4 |
| 6 November 2025 | Gupta Vikas | Chief Investment Officer | Open-market purchase | +11,500 | $42.97 | 13,773 | Form 4 |
| 5 November 2025 | Pickett C Taylor | Chief Executive Officer | Open-market purchase | +20,000 | $43.14 | 20,000 | Form 4 |
| 1 October 2025 | Ballew Neal | Chief Accounting Officer | Grant or award | +201 | $31.16 | 4,204 | Form 4 |
| 1 October 2025 | Ballew Neal | Chief Accounting Officer | Shares withheld for tax | −17 | $42.22 | 4,187 | Form 4 |
| 26 August 2025 | Stephenson Robert O | Chief Financial Officer | Gift | −800 | — | 182,276 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Omega Healthcare Investors page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.